Insider · CIK 0001921163
Asif Ali
cfoofficer
Files at PTGX (Protagonist Therapeutics, Inc). First filing Mar 14, 2025, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $17M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTGX: Protagonist Therapeutics, Inc
PTGXOct 9, 2026 · close 143.73
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Protagonist Therapeutics, Inc | $8.3M 58,629 shares | -50% | +120% from low-11% from high | |
| 42Moderate | PTGXsell Protagonist Therapeutics, Inc | $2.6M 24,765 shares | -29% | +150% from low-2% from high | |
| 42Moderate | PTGXsell Protagonist Therapeutics, Inc | $3.8M 46,203 shares | -43% | +137% from low-13% from high | |
| 43Moderate | PTGXsell Protagonist Therapeutics, Inc | $708k 8,588 shares | -10% | +138% from low-13% from high | |
| 31Weak | PTGXsell Protagonist Therapeutics, Inc | $81k 1,756 shares | -3% | +31% from low-23% from high | |
| 42Moderate | PTGXsell Protagonist Therapeutics, Inc | $1.5M 24,903 shares | -28% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock10b5-1 | +9,229 | $38.98 | $360k | 68,232 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock10b5-1 | +28,438 | $23.42 | $666k | 96,670 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock10b5-1 | +15,650 | $19.19 | $300k | 112,320 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock10b5-1 | +5,312 | $12.17 | $65k | 117,632 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock10b5-1 | -12,595 | $141.77 | $1.8M | 105,037 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock10b5-1 | -46,034 | $141.78 | $6.5M | 59,003 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative10b5-1 | -9,229 | $0.00 | $0 | 29,291 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative10b5-1 | -28,438 | $0.00 | $0 | 49,562 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,650 | $0.00 | $0 | 51,150 | 10 d ago |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,312 | $0.00 | $0 | 25,235 | 10 d ago |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +19,500 | $19.19 | $374k | 80,253 | Mar 27, 2026 |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +5,265 | $12.17 | $64k | 85,518 | Mar 27, 2026 |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -24,765 | $104.24 | $2.6M | 60,753 | Mar 27, 2026 |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -19,500 | $0.00 | $0 | 31,300 | Mar 27, 2026 |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -5,265 | $0.00 | $0 | 13,282 | Mar 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +16,000 | $19.19 | $307k | 94,523 | Jan 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +12,000 | $12.17 | $146k | 106,523 | Jan 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -28,000 | $83.13 | $2.3M | 78,523 | Jan 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -18,203 | $83.14 | $1.5M | 60,320 | Jan 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -16,000 | $0.00 | $0 | 50,800 | Jan 27, 2026 |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -12,000 | $0.00 | $0 | 18,547 | Jan 27, 2026 |
| Jan 20, 2026 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -8,588 | $82.48 | $708k | 78,077 | Jan 21, 2026 |
| Jan 2, 2026 | PTGX Protagonist Therapeutics, Inc | AGrant or award Common Stock | +25,600 | $0.00 | $0 | 86,665 | Jan 6, 2026 |
| Jan 2, 2026 | PTGX Protagonist Therapeutics, Inc | AGrant or award Stock Option (right to buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Jan 6, 2026 |
| Apr 22, 2025 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -1,756 | $46.00 | $81k | 61,065 | Apr 23, 2025 |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +15,203 | $12.17 | $185k | 78,024 | Mar 14, 2025 |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +9,700 | $19.19 | $186k | 87,724 | Mar 14, 2025 |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -24,903 | $58.73 | $1.5M | 62,821 | Mar 14, 2025 |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -15,203 | $0.00 | $0 | 30,547 | Mar 14, 2025 |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -9,700 | $0.00 | $0 | 66,800 | Mar 14, 2025 |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -1,317 | $0.00 | $0 | 65,422 | Jan 17, 2025 |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -2,601 | $0.00 | $0 | 62,821 | Jan 17, 2025 |
| Jan 2, 2025 | PTGX Protagonist Therapeutics, Inc | AGrant or award Common Stock | +31,779 | $0.00 | $0 | 66,739 | Jan 6, 2025 |
| Jan 2, 2025 | PTGX Protagonist Therapeutics, Inc | AGrant or award Stock Option (right to buy)derivative | +38,520 | $0.00 | $0 | 38,520 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.